» Articles » PMID: 18193893

Practical Approach for the Identification and Isomer Elucidation of Biomarkers Detected in a Metabonomic Study for the Discovery of Individuals at Risk for Diabetes by Integrating the Chromatographic and Mass Spectrometric Information

Overview
Journal Anal Chem
Specialty Chemistry
Date 2008 Jan 16
PMID 18193893
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Sensitive and high-resolution chromatographic-driven metabonomomics studies experienced major growth with the aid of new analytical technologies and bioinformatics software packages. Hence, data collections by LC-MS and data analyses by multivariate statistical methods are by far the most straightforward steps, and the detection of biomarker candidates can easily be achieved. However, the unequivocal identification of the detected metabolite candidates, including isomer elucidation, is still a crux of current metabonomics studies. Here we present a comprehensive analytical strategy for the elucidation of the molecular structure of metabolite biomarkers detected in a metabonomics study, exemplified analyzing spot urine of a cohort of healthy, insulin sensitive subjects and clinically well characterized prediabetic, insulin resistant individuals. An integrated approach of LC-MS fingerprinting, multivariate statistic analysis, LC-MSn experiments, micro preparation, FTICR-MS, GC retention index, database search, and generation of an isotope labeled standard was applied. Overall, we could demonstrate the efficiency of our analytical approach by the unambiguous elucidation of the molecular structure of an isomeric biomarker candidate detected in a complex human biofluid. The proposed strategy is a powerful new analytical tool, which will allow the definite identification of physiologically important molecules in metabonomics studies from basic biochemistry to clinical biomarker discovery.

Citing Articles

Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.

Chen J, Lu H, Cao D, Sun J, Qi F, Liu X Metabolomics. 2024; 20(1):18.

PMID: 38281200 DOI: 10.1007/s11306-023-02085-9.


Urine metabolomics for assessing fertility-sparing treatment efficacy in endometrial cancer: a non-invasive approach using ultra-performance liquid chromatography mass spectrometry.

Chen J, Liu J, Cao D BMC Womens Health. 2023; 23(1):583.

PMID: 37940929 PMC: 10634093. DOI: 10.1186/s12905-023-02730-4.


LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer.

Yang M, Liu X, Tang X, Sun W, Ji Z Front Oncol. 2023; 13:1160965.

PMID: 37256175 PMC: 10226587. DOI: 10.3389/fonc.2023.1160965.


Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation.

Zhao M, Liu X, Bu X, Li Y, Wang M, Zhang B PeerJ. 2022; 10:e13853.

PMID: 35966924 PMC: 9373988. DOI: 10.7717/peerj.13853.


Clinical Parameters and Metabolomic Biomarkers That Predict Inhospital Outcomes in Patients With ST-Segment Elevated Myocardial Infarctions.

Liu J, Huang L, Shi X, Gu C, Xu H, Liu S Front Physiol. 2022; 12:820240.

PMID: 35211029 PMC: 8862746. DOI: 10.3389/fphys.2021.820240.